These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3661768)

  • 41. Concentration of prolactin in serum of rats treated with baclofen.
    Ravitz AJ; Moore KE
    J Pharm Pharmacol; 1977 Aug; 29(8):509-10. PubMed ID: 19607
    [No Abstract]   [Full Text] [Related]  

  • 42. Dopaminergic factors in human prolactin regulation: effects of neuroleptics and dopamine.
    Langer G; Sachar EJ
    Psychoneuroendocrinology; 1977 Oct; 2(4):373-8. PubMed ID: 601174
    [No Abstract]   [Full Text] [Related]  

  • 43. Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings].
    Cotes PM; Crow TJ; Johnstone EC
    Br J Clin Pharmacol; 1977 Oct; 4(5):651P. PubMed ID: 911637
    [No Abstract]   [Full Text] [Related]  

  • 44. Prolactin response to repeated electroconvulsive therapy in acute schizophrenia.
    Meco G; Casacchia M; Carchedi F; Falaschi P; Rocco A; Frajese G
    Lancet; 1978 Nov; 2(8097):999. PubMed ID: 82028
    [No Abstract]   [Full Text] [Related]  

  • 45. Cerebrospinal fluid prolactin: a daily rhythm and response to an acute perturbation.
    Perlow MJ
    Brain Res; 1982 Jul; 243(2):382-5. PubMed ID: 7104748
    [No Abstract]   [Full Text] [Related]  

  • 46. Central dopaminergic mechanisms in young patients with essential hypertension.
    Kolloch RE; Stumpe KO; Ismer U; Kletzky O; Dequattro V
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():231s-234s. PubMed ID: 7318328
    [No Abstract]   [Full Text] [Related]  

  • 47. A clinical method for testing abnormal in vitro haemolysis from catecholamine metabolites in schizophrenia.
    Hegedus ZL; Altschule MD; Nayak U
    Br J Psychiatry; 1972 Sep; 121(562):265-9. PubMed ID: 5073780
    [No Abstract]   [Full Text] [Related]  

  • 48. Manganese as a potential confounder of serum prolactin.
    Aschner M
    Environ Health Perspect; 2006 Aug; 114(8):A458; author reply A458. PubMed ID: 16882508
    [No Abstract]   [Full Text] [Related]  

  • 49. Elevated hematocrit in patients with schizophrenia.
    Mathew RJ; Wilson WH
    Biol Psychiatry; 1987 Jul; 22(7):907-10. PubMed ID: 3607118
    [No Abstract]   [Full Text] [Related]  

  • 50. [Abnormal oxidative activity in blood serum in schizophrenia].
    MARTENS S
    Sven Lakartidn; 1957 Mar; 54(12):868-72. PubMed ID: 13433530
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolactin and psychopathology in schizophrenia: a literature review and reappraisal.
    Rajkumar RP
    Schizophr Res Treatment; 2014; 2014():175360. PubMed ID: 24800074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.
    Peuskens J; Pani L; Detraux J; De Hert M
    CNS Drugs; 2014 May; 28(5):421-53. PubMed ID: 24677189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).
    Kelly DL; Wehring HJ; Earl AK; Sullivan KM; Dickerson FB; Feldman S; McMahon RP; Buchanan RW; Warfel D; Keller WR; Fischer BA; Shim JC
    BMC Psychiatry; 2013 Aug; 13():214. PubMed ID: 23968123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
    Haddad PM; Wieck A
    Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
    Markianos M; Sakellariou G; Bistolaki E
    J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abnormal prolactin response to haloperidol challenge in men with schizophrenia.
    Keks NA; Copolov DL; Singh BS
    Am J Psychiatry; 1987 Oct; 144(10):1335-7. PubMed ID: 3661768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
    Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
    Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R; Gonzalez MA; Zumarraga M; Andia I; Guimon J; Silva RR; Friedhoff AJ
    Biol Psychiatry; 1995 Aug; 38(4):267-9. PubMed ID: 8547450
    [No Abstract]   [Full Text] [Related]  

  • 60. Prolactin response to single and multiple doses of haloperidol in schizophrenic patients.
    Ravichandran GK; Lu RB; Shvartsburd A; Misra CH; Ho BT; Kahn M; Smith RC
    Psychiatry Res; 1984 Jan; 11(1):61-9. PubMed ID: 6584932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.